Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists

被引:18
|
作者
Clasby, MC
Chackalamannil, S
Czarniecki, M
Doller, D
Eagen, K
Greenlee, WJ
Lin, Y
Tsai, H
Xia, Y
Ahn, HS
Agans-Fantuzzi, J
Boykow, G
Chintala, M
Foster, C
Bryant, M
Lau, J
机构
[1] Schering Plough Corp, Res Inst, Cent Nervous Syst & Cardiovasc Chem Res, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, Res Inst, Cardiovasc & Metab Dis Res, Kenilworth, NJ 07033 USA
[3] Schering Plough Corp, Res Inst, Drug Metab & Pharmacokinet Res, Kenilworth, NJ 07033 USA
关键词
thrombin; receptor; antagonist; PAR-1; quinoline;
D O I
10.1016/j.bmcl.2005.12.042
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design, synthesis, and SAR studies of a structurally novel series of highly potent thrombin receptor (PAR-1) antagonists are described. Compound 30 is a highly potent thrombin receptor antagonist (IC50 = 6.3 nM), a related compound 36 showing efficacy in a monkey ex vivo study. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1544 / 1548
页数:5
相关论文
共 50 条
  • [21] Novel quinoline-based mGluR5 noncompetitive antagonists
    Zhang, Peng
    Zou, Mu-Fa
    Rodriguez, Alice L.
    Conn, P. Jeffrey
    Newman, Amy H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [22] Design and synthesis of a novel non-peptide mimetic of PAR-1 thrombin receptor with four pharmacophoric groups
    Androutsou, M.
    Alexopoulos, K.
    Mihailescu, S.
    Tselios, T.
    Matsoukas, J.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 120 - 120
  • [23] Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling
    Hoekstra, WJ
    Patel, HS
    Liang, X
    Blanc, JBE
    Heyer, DO
    Willson, TM
    Iannone, MA
    Kadwell, SH
    Miller, LA
    Pearce, KH
    Simmons, CA
    Shearin, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2243 - 2247
  • [24] Himbacine derived thrombin receptor (PAR-1) antagonists: Structure-activity relationship of the lactone ring
    Xia, Yan
    Chackalamannil, Samuel
    Chan, Tze-Ming
    Czarniecki, Michael
    Doller, Dario
    Eagen, Keith
    Greenlee, William J.
    Tsai, Hsingan
    Wang, Yuguang
    Ahn, Ho-Sam
    Boykow, George C.
    McPhail, Andrew T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4969 - 4972
  • [25] Role and regulation of the thrombin receptor (PAR-1) in human melanoma
    Carmen Tellez
    Menashe Bar-Eli
    Oncogene, 2003, 22 : 3130 - 3137
  • [26] Measurement of the thrombin receptor PAR-1 hydrolysis by human α-thrombin on intact platelets
    De Candia, E
    De Cristofaro, R
    Rutella, S
    Rumi, C
    Leone, G
    Landolfi, R
    THROMBOSIS RESEARCH, 1998, 91 (03) : S32 - S32
  • [27] Association of thrombin receptor (PAR-1) gene polymorphism with thromboembolism
    Arnaud, E
    Necaud, V
    Poirier, O
    Rendu, F
    Alhenc-Gelas, M
    Fiessinger, JN
    Emmerich, J
    Alach, M
    THROMBOSIS AND HAEMOSTASIS, 1999, : 850 - 851
  • [28] Role and regulation of the thrombin receptor (PAR-1) in human melanoma
    Tellez, C
    Bar-Eli, M
    ONCOGENE, 2003, 22 (20) : 3130 - 3137
  • [29] Discovery and Synthesis of a Novel Series of Liver X Receptor Antagonists
    Nian, Siyun
    Gan, Xia
    Tan, Xiangduan
    Yu, Zhenpeng
    Wang, Panfeng
    Chen, Xing
    Wang, Guoping
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (08) : 628 - 635
  • [30] Discovery of a non-peptide small molecule antagonist of the human platelet thrombin receptor (PAR-1).
    Selnick, H
    Nantermet, PG
    Rittle, K
    Lundell, GF
    Barrow, JC
    Glass, K
    Young, M
    Pellicore, JM
    Ngo, PL
    Freidinger, R
    Prendergast, K
    Gould, R
    Condra, C
    Karczewski, J
    Connolly, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U540 - U540